Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 9, 2008 - Issue 12
Submit an article Journal homepage
626
Views
33
CrossRef citations to date
0
Altmetric
Reviews

Incomplete remission and treatment resistance in first-episode psychosis: definition, prevalence and predictors

Christian G Huber University Medical Centre Hamburg-Eppendorf, Psychosis Early Detection and Intervention Centre, Centre for Psychosocial Medicine, Department of Psychiatry and Psychotherapy, Martinistreet 52, D-20246 Hamburg, Germany +49 40 42803 3236; +49 40 42803 5455; [email protected]
,
Dieter Naber University Medical Centre Hamburg-Eppendorf, Psychosis Early Detection and Intervention Centre, Centre for Psychosocial Medicine, Department of Psychiatry and Psychotherapy, Martinistreet 52, D-20246 Hamburg, Germany +49 40 42803 3236; +49 40 42803 5455; [email protected]
&
Martin Lambert University Medical Centre Hamburg-Eppendorf, Psychosis Early Detection and Intervention Centre, Centre for Psychosocial Medicine, Department of Psychiatry and Psychotherapy, Martinistreet 52, D-20246 Hamburg, Germany +49 40 42803 3236; +49 40 42803 5455; [email protected]
Pages 2027-2038 | Published online: 31 Jul 2008

Bibliography

  • Conus P, Cotton S, Schimmelmann BG, et al. The First-episode Psychosis Outcome Study: premorbid and baseline characteristics of an epidemiological cohort of 661 first-episode psychosis patients. Early Intervent Psychiatry 2007;1:191-200
  • Schimmelmann BG, Conus P, Edwards J, et al. Diagnostic stability 18 months after treatment initiation for first-episode psychosis. J Clin Psychiatry 2005;66(10):1239-46
  • Andreasen NC, Carpenter WT Jr, Kane JM, et al. Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry 2005;162(3):441-9
  • Lambert M, Naber D, Huber CG. Management of incomplete remission and treatment resistance in first-episode psychosis. Expert Opin Pharmacother 2008;9(12):2039-51
  • Kane J, Honigfeld G, Singer J, Meltzer H. Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch Gen Psychiatry 1988;45(9):789-96
  • Robinson DG, Woerner MG, Alvir JM, et al. Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder. Am J Psychiatry 1999;156(4):544-9
  • Lambert M, Naber D. Current issues in schizophrenia: overview of patient acceptability, functioning capacity and quality of life. CNS Drugs 2004;18 (Suppl 2):5-17; discussion 41-3
  • Kapur S, Remington G, Jones C, et al. High levels of dopamine D2 receptor occupancy with low-dose haloperidol treatment: a PET study. Am J Psychiatry 1996;153(7):948-50
  • Craig T, Fennig S, Tanenberg-Karant M, Bromet EJ. Six-month clinical status as a predictor of 24-month clinical outcome in first-admission patients with schizophrenia. Ann Clin Psychiatry 1999;11(4):197-203
  • Lambert M, Conus P, Klosterkötter J, et al. Results of First-Episode Psychosis Outcome Study (FEPOS) and resulting treatment recommendations. Nervenarzt In press
  • Marneros A. Schizoaffective disorder: clinical aspects, differential diagnosis, and treatment. Curr Psychiatry Rep 2003;5(3):202-5
  • American Psychiatric Association. Practice guideline for the treatment of patients with schizophrenia. In: American Psychiatric Association, editors, Practice guidelines for the treatment of psychiatric disorders, Compendium 2004. 2nd edition. Arlington, VA: American Psychiatric Publishing; 2004. p. 249-440
  • Peuskens J. The evolving definition of treatment resistance. J Clin Psychiatry 1999;60(Suppl 12):4-8
  • Pantelis C, Lambert TJ. Managing patients with ‘treatment-resistant’ schizophrenia. Med J Aust 2003;178(Suppl):S62-6
  • Sachs GS. Treatment-resistant bipolar depression. Psychiatr Clin N Am 1996;19(2):215-36
  • Sackeim HA. The definition and meaning of treatment-resistant depression. J Clin Psychiatry 2001;62(Suppl 16):10-7
  • Goldberg JF, Garno JL, Harrow M. Long-term remission and recovery in bipolar disorder: a review. Curr Psychiatry Rep 2005;7(6):456-61
  • Gitlin MJ. Treatment-resistant bipolar disorder. Bull Menninger Clin 2001;65(1):26-40
  • Gitlin M. Treatment-resistant bipolar disorder. Mol Psychiatry 2006;11(3):227-40
  • Gilmer WS, Trivedi MH, Rush AJ, et al. Factors associated with chronic depressive episodes: a preliminary report from the STAR-D project. Acta Psychiatr Scand 2005;112(6):425-33
  • Malhi GS, Parker GB, Crawford J, et al. Treatment-resistant depression: resistant to definition? Acta Psychiatr Scand 2005;112(4):302-9
  • World Psychiatric Association: Symposium on therapy-resistant depression. Pharmacopsychiatry (1974) 7:69-224.
  • Souery D, Amsterdam J, De Montigny C, et al. Treatment resistant depression: methodological overview and operational criteria. Eur Neuropsychopharmacol 1999;9(1/2):83-91
  • Fava M. Diagnosis and definition of treatment-resistant depression. Biol Psychiatry 2003;53(8):649-59
  • Berlim MT, Turecki G. Definition, assessment, and staging of treatment-resistant refractory major depression: a review of current concepts and methods. Can J Psychiatry 2007;52(1):46-54
  • Buckley PF, Wiggins LD, Sebastian S, Singer B. Treatment-refractory schizophrenia. Curr Psychiatry Rep 2001;3(5):393-400
  • Ram R, Bromet EJ, Eaton WW, et al. The natural course of schizophrenia: a review of first-admission studies. Schizophr Bull 1992;18(2):185-207
  • Hegarty JD, Baldessarini RJ, Tohen M, et al. One hundred years of schizophrenia: a meta-analysis of the outcome literature. Am J Psychiatry 1994;151(10):1409-16
  • Lambert M, Conus P, Schimmelmann BG, et al. Comparison of olanzapine and risperidone in 367 first-episode patients with non-affective or affective psychosis: results of an open retrospective medical record study. Pharmacopsychiatry 2005;38(5):206-13
  • Loebel AD, Lieberman JA, Alvir JM, et al. Duration of psychosis and outcome in first-episode schizophrenia. Am J Psychiatry 1992;149(9):1183-8
  • Lieberman J, Jody D, Geisler S, et al. Time course and biologic correlates of treatment response in first-episode schizophrenia. Arch Gen Psychiatry 1993;50(5):369-76
  • Edwards J, Maude D, McGorry PD, et al. Prolonged recovery in first-episode psychosis. Br J Psychiatry Suppl 1998;172(33):107-16
  • Manchanda R, Norman RM, Malla AK, et al. Persistent psychoses in first episode patients. Schizophr Res 2005;80(1):113-6
  • Wiersma D, Nienhuis FJ, Slooff CJ, Giel R. Natural course of schizophrenic disorders: a 15-year followup of a Dutch incidence cohort. Schizophr Bull 1998;24(1):75-85
  • Harrison G, Hopper K, Craig T, et al. Recovery from psychotic illness: a 15- and 25-year international follow-up study. Br J Psychiatry 2001;178:506-17
  • Robinson DG, Woerner MG, McMeniman M, et al. Symptomatic and functional recovery from a first episode of schizophrenia or schizoaffective disorder. Am J Psychiatry 2004;161(3):473-9
  • Leff J, Sartorius N, Jablensky A, et al. The International Pilot Study of Schizophrenia: five-year follow-up findings. Psychol Med 1992;22(1):131-45
  • Lauronen E, Koskinen J, Veijola J, et al. Recovery from schizophrenic psychoses within the northern Finland 1966 Birth Cohort. J Clin Psychiatry 2005;66(3):375-83
  • Torgalsboen AK, Rund BR. ‘Full recovery’ from schizophrenia in the long term: a ten-year follow-up of eight former schizophrenic patients. Psychiatry 1998;61(1):20-34
  • Tsuang D, Coryell W. An 8-year follow-up of patients with DSM-III-R psychotic depression, schizoaffective disorder, and schizophrenia. Am J Psychiatry 1993;150(8):1182-8
  • Tohen M, Zarate CA Jr, Hennen J, et al. The McLean-Harvard First-episode Mania Study: prediction of recovery and first recurrence. Am J Psychiatry 2003;160(12):2099-107
  • Altshuler LL, Gitlin MJ, Mintz J, et al. Subsyndromal depression is associated with functional impairment in patients with bipolar disorder. J Clin Psychiatry 2002;63(9):807-11
  • Strakowski SM, Delbello MP, Fleck DE, et al. Effects of co-occurring alcohol abuse on the course of bipolar disorder following a first hospitalization for mania. Arch Gen Psychiatry 2005;62(8):851-8
  • Judd LL, Akiskal HS, Schettler PJ, et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry 2002;59(6):530-7
  • Kocsis JH. New strategies for treating chronic depression. J Clin Psychiatry 2000;61(Suppl 11):42-5
  • Kennedy SH, Lam RW, Cohen NL, Ravindran AV. Clinical guidelines for the treatment of depressive disorders. IV. Medications and other biological treatments. Can J Psychiatry 2001;46(Suppl 1:38S-58S
  • Crown WH, Finkelstein S, Berndt ER, et al. The impact of treatment-resistant depression on health care utilization and costs. J Clin Psychiatry 2002;63(11):963-71
  • Maki P, Veijola J, Jones PB, et al. Predictors of schizophrenia – a review. Br Med Bull 2005;73/74:1-15
  • Nasrallah HA. Neurologic comorbidities in schizophrenia. J Clin Psychiatry 2005;66(Suppl 6):34-46
  • Lieberman J, Chakos M, Wu H, et al. Longitudinal study of brain morphology in first episode schizophrenia. Biol Psychiatry 2001;49(6):487-99
  • Milev P, Ho BC, Arndt S, et al. Initial magnetic resonance imaging volumetric brain measurements and outcome in schizophrenia: a prospective longitudinal study with 5-year follow-up. Biol Psychiatry 2003;54(6):608-15
  • Mitelman SA, Shihabuddin L, Brickman AM, et al. Volume of the cingulate and outcome in schizophrenia. Schizophr Res 2005;72(2/3):91-108
  • Staal WG, Hulshoff Pol HE, Schnack HG, et al. Structural brain abnormalities in chronic schizophrenia at the extremes of the outcome spectrum. Am J Psychiatry 2001;158(7):1140-2
  • Ho BC, Andreasen NC, Nopoulos P, et al. Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia. Arch Gen Psychiatry 2003;60(6):585-94
  • Tandon R, Dequardo JR, Taylor SF, et al. Phasic and enduring negative symptoms in schizophrenia: biological markers and relationship to outcome. Schizophr Res 2000;45(3):191-201
  • Rocca P, Bellino S, Calvarese P, et al. Depressive and negative symptoms in schizophrenia: different effects on clinical features. Compr Psychiatry 2005;46(4):304-10
  • Milev P, Ho BC, Arndt S, Andreasen NC. Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up. Am J Psychiatry 2005;162(3):495-506
  • Sharma T, Antonova L. Cognitive function in schizophrenia. Deficits, functional consequences, and future treatment. Psychiatr Clin N Am 2003;26(1):25-40
  • McGurk SR, Meltzer HY. The role of cognition in vocational functioning in schizophrenia. Schizophr Res 2000;45(3):175-84
  • Lysaker PH, Bryson GJ, Bell MD. Insight and work performance in schizophrenia. J Nerv Ment Dis 2002;190(3):142-6
  • Maggini C, Raballo A. Exploring depression in schizophrenia. Eur Psychiatry 2006;21(4):227-32
  • Semiz UB, Cetin M, Basoglu C, et al. Clinical predictors of therapeutic response to clozapine in a sample of Turkish patients with treatment-resistant schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2007;31(6):1330-6
  • Perkins D, Lieberman J, Gu H, et al. Predictors of antipsychotic treatment response in patients with first-episode schizophrenia, schizoaffective and schizophreniform disorders. Br J Psychiatry 2004;185:18-24
  • Strous RD, Alvir JM, Robinson D, et al. Premorbid functioning in schizophrenia: relation to baseline symptoms, treatment response, and medication side effects. Schizophr Bull 2004;30(2):265-78
  • Larsen TK, Friis S, Haahr U, et al. Premorbid adjustment in first-episode non-affective psychosis: distinct patterns of pre-onset course. Br J Psychiatry 2004;185:108-15
  • Browne S, Clarke M, Gervin M, et al. Determinants of quality of life at first presentation with schizophrenia. Br J Psychiatry 2000;176:173-6
  • Malla AK, Norman RM, Manchanda R, et al. One year outcome in first episode psychosis: influence of DUP and other predictors. Schizophr Res 2002;54(3):231-42
  • Lambert M, Conus P, Lubman DI, et al. The impact of substance use disorders on clinical outcome in 643 patients with first-episode psychosis. Acta Psychiatr Scand 2005;112(2):141-8
  • Green AI, Canuso CM, Brenner MJ, Wojcik JD. Detection and management of comorbidity in patients with schizophrenia. Psychiatr Clin N Am 2003;26(1):115-39
  • Ongur D, Goff DC. Obsessive-compulsive symptoms in schizophrenia: associated clinical features, cognitive function and medication status. Schizophr Res 2005;75(2/3):349-62
  • Braga RJ, Petrides G, Figueira I. Anxiety disorders in schizophrenia. Compr Psychiatry 2004;45(6):460-8
  • Kennedy JS, Jeste D, Kaiser CJ, et al. Olanzapine vs haloperidol in geriatric schizophrenia: analysis of data from a double-blind controlled trial. Int J Geriatr Psychiatry 2003;18(11):1013-20
  • Kumra S, Shaw M, Merka P, et al. Childhood-onset schizophrenia: research update. Can J Psychiatry 2001;46(10):923-30
  • Meltzer HY, Rabinowitz J, Lee MA, et al. Age at onset and gender of schizophrenic patients in relation to neuroleptic resistance. Am J Psychiatry 1997;154(4):475-82
  • Hollis C. Adult outcomes of child- and adolescent-onset schizophrenia: diagnostic stability and predictive validity. Am J Psychiatry 2000;157(10):1652-9
  • Fenton WS, Blyler CR, Heinssen RK. Determinants of medication compliance in schizophrenia: empirical and clinical findings. Schizophr Bull 1997;23(4):637-51
  • Lacro JP, Dunn LB, Dolder CR, et al. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatry 2002;63(10):892-909
  • Lindenmayer JP. Treatment refractory schizophrenia. Psychiatr Q 2000;71(4):373-84
  • Lieberman JA, Koreen AR, Chakos M, et al. Factors influencing treatment response and outcome of first-episode schizophrenia: implications for understanding the pathophysiology of schizophrenia. J Clin Psychiatry 1996;57(Suppl 9):5-9
  • Mintz AR, Dobson KS, Romney DM. Insight in schizophrenia: a meta-analysis. Schizophr Res 2003;61(1):75-88
  • McKenzie K, Van Os J, Fahy T, et al. Psychosis with good prognosis in Afro-Caribbean people now living in the United Kingdom. BMJ 1995;311(7016):1325-8
  • Murray RM, Van Os J. Predictors of outcome in schizophrenia. J Clin Psychopharmacol 1998;18(2 Suppl 1):2S-4S
  • Kavanagh DJ: Recent developments in expressed emotion and schizophrenia. Br J Psychiatry 1992;160:601-20
  • Sandson NB, Armstrong SC, Cozza KL. An overview of psychotropic drug-drug interactions. Psychosomatics 2005;46(5):464-94
  • Malhotra AK, Murphy GM Jr, Kennedy JL. Pharmacogenetics of psychotropic drug response. Am J Psychiatry 2004;161(5):780-96
  • Pantelis C, Velakoulis D, McGorry PD, et al. Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet 2003;361(9354):281-8
  • Schimmelmann BG, Huber CG, Lambert M, et al. Impact of duration of untreated psychosis on pre-treatment, baseline, and outcome characteristics in an epidemiological first-episode psychosis cohort. J Psychiatr Research 2008; doi: 10.1016/j.jpsychires.2007.12.001
  • Ucok A, Polat A, Genc A, et al. Duration of untreated psychosis may predict acute treatment response in first-episode schizophrenia. J Psychiatr Res 2004;38(2):163-8
  • Harrigan SM, McGorry PD, Krstev H. Does treatment delay in first-episode psychosis really matter? Psychol Med 2003;33(1):97-110
  • Marshall M, Lewis S, Lockwood A, et al. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Arch Gen Psychiatry 2005;62(9):975-83
  • Bottlender R, Sato T, Jager M, et al. The impact of the duration of untreated psychosis prior to first psychiatric admission on the 15-year outcome in schizophrenia. Schizophr Res 2003;62(1/2):37-44
  • Harris MG, Henry LP, Harrigan SM, et al. The relationship between duration of untreated psychosis and outcome: an eight-year prospective study. Schizophr Res 2005;79(1):85-93
  • Royal Australian And New Zealand College Of Psychiatrists. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders. Aust NZ J Psychiatry 2005;39(1/2):1-30
  • Lambert M, Naber D, editors. Current schizophrenia. Hamburg: Science Press; 2004
  • Moore PB, Shepherd DJ, Eccleston D, et al. Cerebral white matter lesions in bipolar affective disorder: relationship to outcome. Br J Psychiatry 2001;178:172-6
  • Doris A, Belton E, Ebmeier KP, et al. Reduction of cingulate gray matter density in poor outcome bipolar illness. Psychiatry Res. 2004;130(2):153-9
  • Strakowski SM, Delbello MP, Zimmerman ME, et al. Ventricular and periventricular structural volumes in first- versus multiple-episode bipolar disorder. Am J Psychiatry 2002;159(11):1841-7
  • Bearden CE, Hoffman KM, Cannon TD. The neuropsychology and neuroanatomy of bipolar affective disorder: a critical review. Bipolar Dis 2001;3(3):106-50; discussion 103-51
  • Baethge C, Smolka MN, Gruschka P, et al. Does prophylaxis-delay in bipolar disorder influence outcome? Results from a long-term study of 147 patients. Acta Psychiatr Scand 2003;107(4):260-7
  • Bowden CL. Relationship of acute mania symptomatology to maintenance treatment response. Curr Psychiatry Rep 2004;6(6):473-77
  • Nolen WA, Luckenbaugh DA, Altshuler LL, et al. Correlates of 1-year prospective outcome in bipolar disorder: results from the Stanley Foundation Bipolar Network. Am J Psychiatry 2004;161(8):1447-54
  • Bauer MS, Kirk GF, Gavin C, Williford WO. Determinants of functional outcome and healthcare costs in bipolar disorder: a high-intensity follow-up study. J Affect Dis 2001;65(3):231-41
  • Martinez-Aran A, Vieta E, Colom F, et al. Neuropsychological performance in depressed and euthymic bipolar patients. Neuropsychobiology 2002;46(Suppl 1):16-21
  • Coryell W, Turvey C, Endicott J, et al. Bipolar I affective disorder: predictors of outcome after 15 years. J Affect Dis 1998;50(2/3):109-16
  • Tsai SM, Chen C, Kuo C, et al. 15-year outcome of treated bipolar disorder. J Affect Dis 2001;63(1/3):215-20
  • Boylan KR, Bieling PJ, Marriott M, et al. Impact of comorbid anxiety disorders on outcome in a cohort of patients with bipolar disorder. J Clin Psychiatry 2004;65(8):1106-13
  • Gaudiano BA, Miller IW. Anxiety disorder comorbidity in bipolar I disorder: relationship to depression severity and treatment outcome. Depress Anxiety 2005;21(2):71-7
  • Carter TD, Mundo E, Parikh SV, Kennedy JL. Early age at onset as a risk factor for poor outcome of bipolar disorder. J Psychiatr Res 2003;37(4):297-303
  • Chengappa KN, Baker RW, Shao L, et al. Rates of response, euthymia and remission in two placebo-controlled olanzapine trials for bipolar mania. Bipolar Dis 2003;5(1):1-5
  • Hirschfeld RM, Calabrese JR, Weissman MM, et al. Screening for bipolar disorder in the community. J Clin Psychiatry 2003;64(1):53-9
  • Keck PE Jr, McElroy SL, Strakowski SM, et al. 12-month outcome of patients with bipolar disorder following hospitalization for a manic or mixed episode. Am J Psychiatry 1998;155(5):646-52
  • Baldessarini RJ, Tondo L, Hennen J. Treatment-latency and previous episodes: relationships to pretreatment morbidity and response to maintenance treatment in bipolar I and Ii disorders. Bipolar Dis 2003;5(3):169-79
  • Craig TJ, Grossman S, Mojtabai R, et al. Medication use patterns and 2-year outcome in first-admission bipolar disorder with psychotic features. Bipolar Dis 2004;6(5):406-15
  • Perlis RH, Miyahara S, Marangell LB, et al. Long-term implications of early onset in bipolar disorder: data from the first 1000 participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD). Biol Psychiatry 2004;55(9):875-81
  • Howland RH. Thyroid dysfunction in refractory depression: implications for pathophysiology and treatment. J Clin Psychiatry 1993;54(2):47-54
  • Kornstein SG, Schneider RK. Clinical features of treatment-resistant depression. J Clin Psychiatry 2001;62(Suppl 16):18-25
  • Thase ME. Treatment of severe depression. J Clin Psychiatry 2000;61(Suppl 1):17-25
  • Scott J, Williams JM, Brittlebank A, Ferrier IN. The relationship between premorbid neuroticism, cognitive dysfunction and persistence of depression: a 1-year follow-up. J Affect Dis 1995;33(3):167-72
  • Klein DN, Schatzberg AF, McCullough JP, et al. Age of onset in chronic major depression: relation to demographic and clinical variables, family history, and treatment response. J Affect Dis 1999;55(2/3):149-57
  • Scott J, Barker WA, Eccleston D. The Newcastle Chronic Depression Study. Patient characteristics and factors associated with chronicity. Br J Psychiatry 1988;152:28-33
  • Wetter TC, Ising M. Association between polymorphism within the promoter region of the serotonin transporter gene and treatment response in depression – further evidence but still controversial issues. Sleep Med 2004;5(1):93-5
  • Hirschfeld RM. Clinical importance of long-term antidepressant treatment. Br J Psychiatry Suppl 2001;42:S4-8
  • Melle I, Larsen TK, Haahr U, et al. Reducing the duration of untreated first-episode psychosis: effects on clinical presentation. Arch Gen Psychiatry 2004;61(2):143-50
  • Wunderink A, Nienhuis FJ, Sytema S, Wiersma D. Treatment delay and response rate in first episode psychosis. Acta Psychiatr Scand 2006;113(4):332-9
  • Drake RE, Mueser KT, Torrey WC, et al. Evidence-based treatment of schizophrenia. Curr Psychiatry Rep 2000;2(5):393-7

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.